Zimmer Biomet Holdings, Inc.

Equities

ZBH

US98956P1021

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:01 2024-04-18 pm EDT			5-day change	1st Jan Change
119.3 ^USD	-1.62%		-6.42%	-1.95%

Apr. 15	Truist Securities Adjusts Zimmer Biomet Price Target to $137 From $135, Hold Rating Kept	MT
Apr. 04	Zimmer Biomet Partners with Three Pickleball Organizations in US	MT

Zimmer Biomet Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022

April 28, 2022 at 08:31 am EDT

Zimmer Biomet Holdings, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 1,601.4 million. Net income was USD 198.1 million. Basic earnings per share from continuing operations was USD 0.93. Diluted earnings per share from continuing operations was USD 0.92. Basic earnings per share was USD 0.95. Diluted earnings per share was USD 0.94.

Latest news about Zimmer Biomet Holdings, Inc.

Truist Securities Adjusts Zimmer Biomet Price Target to $137 From $135, Hold Rating Kept	Apr. 15	MT
Zimmer Biomet Partners with Three Pickleball Organizations in US	Apr. 04	MT
Citigroup Raises Price Target on Zimmer Biomet to $140 From $134, Keeps Neutral Rating	Apr. 03	MT
3M Board Approves Healthcare Unit Spinoff -- Update	Mar. 08	DJ
Zimmer Biomet's ROSA Shoulder Replacement Platform Receives FDA Clearance	Feb. 22	MT
Zimmer Biomet Holdings, Inc. Announces U.S. Food and Drug Administration 510(K) Clearance of the Rosa® Shoulder System for Robotic-Assisted Shoulder Replacement Surgery	Feb. 22	CI
Zimmer Biomet Maintains Quarterly Dividend at $0.24 a Share, Payable by April 30 to Shareholders of Record March 29	Feb. 21	MT
Zimmer Biomet Holdings, Inc. Announces Quarterly Cash Dividend for the First Quarter of 2024, Payable on or About April 30, 2024	Feb. 21	CI
Smith & Nephew Q4 Margin in Focus, Outlook Upgrade Likely, RBC Says	Feb. 12	MT
Zimmer Biomet Holdings, Inc. Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting	Feb. 12	CI
UBS Adjusts Zimmer Biomet Price Target to $109 From $105, Maintains Sell Rating	Feb. 09	MT
Deutsche Bank Adjusts Zimmer Biomet Price Target to $140 From $147, Maintains Hold Rating	Feb. 09	MT
Zimmer Biomet Seeks M&A	Feb. 08	CI
Transcript : Zimmer Biomet Holdings, Inc., Q4 2023 Earnings Call, Feb 08, 2024	Feb. 08
Zimmer Biomet forecasts upbeat 2024 profit on steady medical devices demand	Feb. 08	RE
Zimmer Biomet Q4 Adjusted Earnings, Net Sales Increase; Issues 2024 Guidance	Feb. 08	MT
(ZBH) ZIMMER BIOMET HOLDINGS Expects Fiscal Year 2024 EPS Range $8.00 - $8.15	Feb. 08	MT
Earnings Flash (ZBH) ZIMMER BIOMET HOLDINGS Posts Q4 Revenue $1.94B, vs. Street Est of $1.93B	Feb. 08	MT
Earnings Flash (ZBH) ZIMMER BIOMET HOLDINGS Reports Q4 EPS $2.20, vs. Street Est of $2.16	Feb. 08	MT
Tranche Update on Zimmer Biomet Holdings, Inc.'s Equity Buyback Plan announced on February 24, 2016.	Feb. 08	CI
Zimmer Biomet Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 08	CI
Zimmer Biomet Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 08	CI
Zimmer Biomet Holdings, Inc. Provides Earnings Guidance for the Full Year 2024	Feb. 08	CI
North American Morning Briefing : S&P 500 to Open -2-	Feb. 08	DJ
MORNING BID AMERICAS-Record S&P500 eyes 5,000, China deflated	Feb. 08	RE

Chart Zimmer Biomet Holdings, Inc.

Duration

Period

More charts

Company Profile

Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows: - reconstruction implants (57.5%): knees replacement (58.8% of net sales), hips replacement (41.2%); - surgical products and traumatology equipment (22.1%); - dental, spinal and craniomaxillofacial implants (12.8%); - other (7.6%): primarily orthopedic surgery materials and instruments used during post-operative rehabilitation. At the end of 2021, the group had approximately 30 production sites worldwide. Net sales are distributed geographically as follows: Americas (61.3%), Europe/Middle East/Africa (21.3%) and Asia/Pacific (17.4%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-02 - Q1 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Zimmer Biomet Holdings, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

119.3 USD

Average target price

137.1 USD

Spread / Average Target

+14.93%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ZIMMER BIOMET HOLDINGS, INC.	-1.95%	24.52B
ABBOTT LABORATORIES	-4.36%	183B
MEDTRONIC PLC	-3.87%	105B
BECTON, DICKINSON AND COMPANY	-4.38%	67.36B
DEXCOM, INC.	+8.23%	51.77B
CENCORA, INC.	+15.54%	47.29B
HOYA CORPORATION	-1.73%	40.2B
WEST PHARMACEUTICAL SERVICES, INC.	+7.16%	27.62B
SARTORIUS STEDIM BIOTECH	-16.81%	21.75B
METTLER-TOLEDO INTERNATIONAL, INC.	-1.68%	25.51B

Other Medical Equipment, Supplies & Distribution